Despite lower returns in the short term, the reinvestment fo...

Despite lower returns in the short term, the reinvestment for growth and higher sales at Chengdu Bright Eye Hospital are encouraging. However, the stock has fallen 34% over the last year, which may warrant further investigation into this stock.